NCT03655678 A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia Status COMPLETED Phase PHASE2/PHASE3
NCT03651102 Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia Status COMPLETED Phase PHASE2/PHASE3
NCT03609840 Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients Status COMPLETED Phase N/A
NCT03609827 Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients Status COMPLETED Phase N/A
NCT03609814 Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) Status COMPLETED Phase N/A
NCT03513328 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT03402191 L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension Status UNKNOWN Phase PHASE4
NCT03392298 Study on the Mechanism of Colla Corri Asini in the Treatment of Thalassemia Patients With Pregnancy Anemia Status UNKNOWN Phase PHASE4
NCT03374111 Colla Corii Asini Treating Anemia in Pregnant Women With Thalassemia(Presenting the Syndrome of Blood Deficiency) Status UNKNOWN Phase PHASE4
NCT03367546 Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases Status TERMINATED Phase PHASE2
NCT03342404 A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia Status COMPLETED Phase PHASE2
NCT03333486 Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer Status TERMINATED Phase PHASE2
NCT03249831 A Blood Stem Cell Transplant for Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03170245 Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients Status COMPLETED Phase N/A
NCT03165864 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered Subcutaneously to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03117192 Zinc Supplementation on Cellular Immunity in Thalassemia Major Status COMPLETED Phase PHASE4
NCT03095326 Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia Status COMPLETED Phase PHASE4
NCT03032666 Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial Status COMPLETED Phase PHASE4